Abstract:Most therapies used in patients affected by inflammatory bowel diseases are ineffective in preventing the development of chronic visceral hypersensitivity, mainly due to inflammation-induced enteric neuroplasticity. Glucosinolates, secondary metabolites mainly of Brassicaceae with anti-inflammatory and neuroprotective properties, are effective in treating both neuropathic and arthritis pain through H2S release and Kv7 potassium channel activation. The aim of this work was to investigate the protective and anti… Show more
“…In this context, Brassicaceae plants emerged to be ideal candidates, since the ITCs contained in these plants can modulate both inflammatory response and oxidative stress [ 9 , 10 ]; they also display potential benefits for the gut microbiota [ 12 , 13 , 14 , 56 ], which has high relevance in gut pain associated with colitis [ 17 , 57 , 58 ]. Several studies in the literature attest that ITCs are effective against both inflammatory and neuropathic pain by the slow release of H 2 S in vivo , and by the positive modulation of Kv7 potassium channels activity [ 18 , 20 , 21 , 25 , 59 ], which are involved in different physiological processes like the regulation of blood pressure and the transmission of painful stimuli [ 11 , 19 , 60 , 61 , 62 ].…”
Section: Discussionmentioning
confidence: 99%
“…Compounds were acutely administered as follows. The doses of Camelina sativa DSM (0.1–1 g kg −1 po) were chosen based on previous evidence [ 25 ]. Camelina sativa DSM was bioactivated by adding 30 μL mL −1 of myrosinase (32 U mL −1 ) 15 min before the administration.…”
Section: Methodsmentioning
confidence: 99%
“…ITCs also display a prebiotic activity [ 12 , 13 , 14 ] that is highly relevant in the context of gut pain [ 15 , 16 , 17 ]. Notably, ITCs are effective against a wide range of inflammatory and neuropathic pain conditions by the slow release of H 2 S in vivo [ 11 , 18 , 19 ], followed by the activation of Kv7 potassium channels [ 18 , 20 , 21 ], which are involved in the transmission of painful stimuli [ 19 , 22 ] also from the viscera [ 23 , 24 , 25 ].…”
Brassicaceae are natural sources of bioactive compounds able to promote gut health. Belonging to this plant family, Camelina sativa is an ancient oil crop rich in glucosinolates, polyunsaturated fatty acids, and antioxidants that is attracting renewed attention for its nutraceutical potential. This work aimed at investigating the therapeutic effects of a defatted seed meal (DSM) of Camelina sativa on the colon damage and the persistent visceral hypersensitivity associated with colitis in rats. Inflammation was induced by the intrarectal injection of 2,4-dinitrobenzenesulfonic acid (DNBS). The acute administration of Camelina sativa DSM (0.1–1 g kg−1) showed a dose-dependent pain-relieving effect in DNBS-treated rats. The efficacy of the meal was slightly enhanced after bioactivation with myrosinase, which increased isothiocyanate availability, and drastically decreased by pre-treating the animals with the selective peroxisome proliferator-activated receptor alpha (PPAR α) receptor antagonist GW6471. Repeated treatments with Camelina sativa DSM (1 g kg−1) meal counteracted the development, as well as the persistence, of visceral hyperalgesia in DNBS-treated animals by reducing the intestinal inflammatory damage and preventing enteric neuron damage. In conclusion, Camelina sativa meal might be employed as a nutraceutical tool to manage persistent abdominal pain in patients and to promote gut healing.
“…In this context, Brassicaceae plants emerged to be ideal candidates, since the ITCs contained in these plants can modulate both inflammatory response and oxidative stress [ 9 , 10 ]; they also display potential benefits for the gut microbiota [ 12 , 13 , 14 , 56 ], which has high relevance in gut pain associated with colitis [ 17 , 57 , 58 ]. Several studies in the literature attest that ITCs are effective against both inflammatory and neuropathic pain by the slow release of H 2 S in vivo , and by the positive modulation of Kv7 potassium channels activity [ 18 , 20 , 21 , 25 , 59 ], which are involved in different physiological processes like the regulation of blood pressure and the transmission of painful stimuli [ 11 , 19 , 60 , 61 , 62 ].…”
Section: Discussionmentioning
confidence: 99%
“…Compounds were acutely administered as follows. The doses of Camelina sativa DSM (0.1–1 g kg −1 po) were chosen based on previous evidence [ 25 ]. Camelina sativa DSM was bioactivated by adding 30 μL mL −1 of myrosinase (32 U mL −1 ) 15 min before the administration.…”
Section: Methodsmentioning
confidence: 99%
“…ITCs also display a prebiotic activity [ 12 , 13 , 14 ] that is highly relevant in the context of gut pain [ 15 , 16 , 17 ]. Notably, ITCs are effective against a wide range of inflammatory and neuropathic pain conditions by the slow release of H 2 S in vivo [ 11 , 18 , 19 ], followed by the activation of Kv7 potassium channels [ 18 , 20 , 21 ], which are involved in the transmission of painful stimuli [ 19 , 22 ] also from the viscera [ 23 , 24 , 25 ].…”
Brassicaceae are natural sources of bioactive compounds able to promote gut health. Belonging to this plant family, Camelina sativa is an ancient oil crop rich in glucosinolates, polyunsaturated fatty acids, and antioxidants that is attracting renewed attention for its nutraceutical potential. This work aimed at investigating the therapeutic effects of a defatted seed meal (DSM) of Camelina sativa on the colon damage and the persistent visceral hypersensitivity associated with colitis in rats. Inflammation was induced by the intrarectal injection of 2,4-dinitrobenzenesulfonic acid (DNBS). The acute administration of Camelina sativa DSM (0.1–1 g kg−1) showed a dose-dependent pain-relieving effect in DNBS-treated rats. The efficacy of the meal was slightly enhanced after bioactivation with myrosinase, which increased isothiocyanate availability, and drastically decreased by pre-treating the animals with the selective peroxisome proliferator-activated receptor alpha (PPAR α) receptor antagonist GW6471. Repeated treatments with Camelina sativa DSM (1 g kg−1) meal counteracted the development, as well as the persistence, of visceral hyperalgesia in DNBS-treated animals by reducing the intestinal inflammatory damage and preventing enteric neuron damage. In conclusion, Camelina sativa meal might be employed as a nutraceutical tool to manage persistent abdominal pain in patients and to promote gut healing.
“…Looking at H&E-stained colon slices (Figure 2D and Figure S1), it was observed that after the interventive treatment with ALCAR, the submucosa of DNBS animals was significantly less thick in comparison to that of DNBS + vehicle animals (black double arrows), the mucosa was almost restored, and the inflammatory infiltrate was restricted to the submucosa (white arrows). An increased mast cell and eosinophil infiltration within the colon is one of the peripheral mechanisms that has been associated with visceral sensitivity persistence [3,32], and it is usually reduced by treatment that prevents pain establishment by protecting the colon from the inflammatory insult [30,33,34]. Regarding the effect of ALCAR, neither the preventive nor the interventive protocol had any effect on mast cell and eosinophil infiltration in the submucosae of DNBS-treated animals (Figure 2E,F), as clearly emerges in the representative picture, showing mast cell granules stained in purple and eosinophils stained in pink with GIEMSA (Figure 2G and Figure S2).…”
Section: Effect Of Alcar On Colon Damage and Mast Cell/eosinophils In...mentioning
The management of abdominal pain in patients affected by inflammatory bowel diseases (IBDs) still represents a problem because of the lack of effective treatments. Acetyl L-carnitine (ALCAR) has proved useful in the treatment of different types of chronic pain with excellent tolerability. The present work aimed at evaluating the anti-hyperalgesic efficacy of ALCAR in a model of persistent visceral pain associated with colitis induced by 2,4-dinitrobenzene sulfonic acid (DNBS) injection. Two different protocols were applied. In the preventive protocol, ALCAR was administered daily starting 14 days to 24 h before the delivery of DNBS. In the interventive protocol, ALCAR was daily administered starting the same day of DNBS injection, and the treatment was continued for 14 days. In both cases, ALCAR significantly reduced the establishment of visceral hyperalgesia in DNBS-treated animals, though the interventive protocol showed a greater efficacy than the preventive one. The interventive protocol partially reduced colon damage in rats, counteracting enteric glia and spinal astrocyte activation resulting from colitis, as analyzed by immunofluorescence. On the other hand, the preventive protocol effectively protected enteric neurons from the inflammatory insult. These findings suggest the putative usefulness of ALCAR as a food supplement for patients suffering from IBDs.
“…The same research group demonstrated that the water extract of Brassicaceae plant Eruca sativa Mill, displays visceral anti-nociceptive effect in a DNBS- rat model. This effect, attributable to the high glucosinolate content, was suggested to be due to the release of hydrogen sulphide (H 2 S) and the positive modulation of Kv 7 potassium channel activity [ 95 ]. The Brassicaceae Maca ( Lepidium meyenii ) is the only source of Macamides, a class of bioactive amide alkaloids.…”
Section: Brassicaceae and Inflammation: Evidence Of Anti-inflammatory...mentioning
Inflammatory bowel disease (IBD) is a group of intestinal disorders, of unknown etiology, characterized by chronic inflammation within the gut. They are gradually becoming critical because of the increasing incidence worldwide and improved diagnosis. Due to the important side effects observed during conventional therapy, natural bioactive components are now under intense investigation for the prevention and treatment of chronic illnesses. The Brassicaceae family comprises vegetables widely consumed all over the world. In recent decades, a growing body of literature has reported that extracts from the Brassicaceae family and their purified constituents have anti-inflammatory properties, which has generated interest from both the scientific community and clinicians. In this review, data from the literature are scrutinized and concisely presented demonstrating that Brassicaceae may have anti-IBD potential. The excellent biological activities of Brassicacea are widely attributable to their ability to regulate the levels of inflammatory and oxidant mediators, as well as their capacity for immunomodulatory regulation, maintenance of intestinal barrier integrity and intestinal flora balance. Possible future applications of bioactive-derived compounds from Brassicaceae for promoting intestinal health should be investigated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.